The remaining workforce, led by senior medical adviser David Hough, MD, will focus on clinical development and FDA engagement, according to an Aug. 15 news release from Lykos.
Dr. Hough previously served as vice president of research and development at Johnson & Johnson Innovative Medicine.
As part of the reorganization, Rick Doblin, PhD, will step down from Lykos’ board of directors. Dr. Doblin is the founder and president of the nonprofit behind Lykos, Multidisciplinary Association for Psychedelic Studies.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
